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Abstract
Background
Universal coverage with long-lasting insecticidal nets (LLINs) is a primary control strategy
against Plasmodium falciparum malaria. However, its impact on the three other main spe-
cies of human malaria and lymphatic filariasis (LF), which share the same vectors in many
co-endemic areas, is not as well characterized. The recent development of multiplex anti-
body detection provides the opportunity for simultaneous evaluation of the impact of control
measures on the burden of multiple diseases.
Methodology/Principal findings
Two cross-sectional household surveys at baseline and one year after a LLIN distribution
campaign were implemented in Mecubu´ri and Nacala-a-Velha Districts in Nampula Prov-
ince, Mozambique. Both districts were known to be endemic for LF; both received mass
drug administration (MDA) with antifilarial drugs during the evaluation period. Access to and
use of LLINs was recorded, and household members were tested with P. falciparum rapid
diagnostic tests (RDTs). Dried blood spots were collected and analyzed for presence of anti-
bodies to three P. falciparum antigens, P. vivax MSP-119, P. ovale MSP-119, P. malariae
MSP-119, and three LF antigens. Seroconversion rates were calculated and the association
between LLIN use and post-campaign seropositivity was estimated using multivariate
regression. The campaign covered 68% (95% CI: 58–77) of the population in Nacala-a-
Velha and 46% (37–56) in Mecubu´ri. There was no statistically significant change in P.
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falciparum RDT positivity between the two surveys. Population seropositivity at baseline
ranged from 31–81% for the P. falciparum antigens, 3–4% for P. vivax MSP-119, 41–43%
for P. ovale MSP-119, 46–56% for P. malariae MSP-119, and 37–76% for the LF antigens.
The seroconversion rate to the LF Bm33 antigen decreased significantly in both districts.
The seroconversion rate to P. malariae MSP-119 and the LF Wb123 and Bm14 antigens
each decreased significantly in one of the two districts. Community LLIN use was associated
with a decreased risk of P. falciparum RDT positivity, P. falciparum LSA-1 seropositivity,
and P. malariae MSP-119 seropositivity, but not LF antigen seropositivity.
Conclusions/Significance
The study area noted significant declines in LF seropositivity, but these were not associated
with LLIN use. The MDA could have masked any impact of the LLINs on population LF sero-
positivity. The LLIN campaign did not reach adequately high coverage to decrease P. falcip-
arum RDT positivity, the most common measure of P. falciparum burden. However, the
significant decreases in the seroconversion rate to the P. malariae antigen, coupled with an
association between community LLIN use and individual-level decreases in seropositivity to
P. falciparum and P. malariae antigens show evidence of impact of the LLIN campaign and
highlight the utility of using multiantigenic serological approaches for measuring intervention
impact.
Author summary
Plasmodium falciparum malaria is the principal cause of illness and death in Mozambique.
However, the same mosquitoes that transmit P. falciparum parasites also transmit three
other species of malaria (P. malariae, P. ovale, and P. vivax) and the worm that causes
lymphatic filariasis. To date, we do not know how much transmission of the three other
species of malaria occurs. We also do not know if control interventions such as the distri-
bution of bed nets reduce the transmission of lymphatic filariasis and non-falciparum
malaria. To address this question, we sampled community members immediately follow-
ing and one year after a bed net distribution campaign in Mozambique. We analyzed their
blood for the presence of antibodies to four species of malaria and lymphatic filariasis.
We found that a substantial proportion of individuals had antibodies to P. falciparum,
P. malariae, P. ovale, and the worms causing lymphatic filariasis. We found much lower
rates of seropositivity to P. vivax. Individuals reporting using bed nets had a lower risk of
testing positive for P. falciparum and P. malariae antibodies. The proportion of the popu-
lation with access to and using bed nets was too low to cause a population-wide decrease
in malaria transmission. There was a significant decline in lymphatic filariasis seropositiv-
ity between the two surveys, but we could not attribute it to the bed net distribution cam-
paign. Measuring antibody levels for multiple diseases simultaneously has utility in
assessing intervention impact.
Introduction
Northern Mozambique has one of the highest rates of Plasmodium falciparum transmission
and disease burden in the world [1]. As in the rest of Mozambique, infection with P.
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falciparum malaria parasites is among the principal causes of outpatient visits, hospitalizations,
and deaths. Malaria transmission occurs year-round and P. falciparum prevalence in children
under 5 was measured to reach up to 65% in the central and northern provinces in 2015 [2].
Although P. falciparum parasites are the most deadly and common agent transmitted by
Anopheles vectors in Mozambique, anopheline mosquitoes are also responsible for transmis-
sion of three other species of human malaria–P. malariae, P. ovale, and P. vivax–as well as the
lymphatic filariasis (LF) parasite Wuchereria bancrofti. In contrast to P. falciparum, the distri-
bution and burden of non-falciparum malaria and LF in Mozambique, as in most of sub-Saha-
ran Africa, has not been well characterized. Reasons for this include poor diagnostic capability,
less severe manifestations of disease, and less attention and funding from ministries of health
and international donors. In general, P. vivax has historically been thought to be largely absent
from sub-Saharan Africa due to the lack of the Duffy coat receptor in populations originating
in West Africa [3]. Although P. ovale and P. malariae are thought to be in circulation in
Mozambique, estimating their incidence of infection has been difficult, particularly since they
are typically present at low parasite densities and are difficult to detect through slide micros-
copy, especially in the presence of a concomitant P. falciparum infection. Lymphatic filariasis
has been mapped to be most prevalent in northern and central Mozambique [4], but the highly
focal nature of LF transmission and the delay between infection and development of disease
makes surveillance of this major cause of disability difficult.
Currently, the most effective strategies for reducing the burden of P. falciparum infection
focus on vector control [5]. In Mozambique, Anopheles mosquitoes are targeted by indoor
residual spraying with insecticides and the distribution and use of long-lasting insecticidal nets
(LLINs), which, in addition to protecting the user with a physical barrier, in practice also func-
tion as human-baited insecticidal mosquito traps and can significantly reduce mosquito popu-
lations [6]. The Mozambican National Malaria Control Program (NMCP) adopted a strategy
of universal coverage with LLINs throughout the country in 2010–2011, aiming to cover each
sleeping space with an LLIN. Implementation began with a series of sub-provincial mass distri-
bution campaigns, some of which were implemented by the Ministry of Health and local
authorities, and some by non-governmental partner organizations. Although primarily used to
prevent P. falciparum infections, LLINs are known to reduce transmission of P. vivax [6] and
have been postulated to also reduce transmission of P. ovale and P. malariae [7] and the LF
parasites through their effect on the common vector [8]. Although there is some evidence of
the impact of LLINs on LF transmission [8, 9], nets have not been widely adopted as a primary
intervention against LF, with current strategies largely limited to mass drug administrations
(MDAs) of the antifilarial drugs ivermectin or diethylcarbamazine in combination with alben-
dazole [10].
As part of its monitoring and evaluation program, the Mozambican NMCP periodically
evaluates LLIN distribution campaigns. The objectives are to both monitor the operational
performance of the campaigns, as assessed through coverage and usage indicators, as well as to
measure the impact of the campaigns on malaria prevalence and estimates of transmission.
The latter is particularly important amid the rise of insecticide resistance and the potential for
diminishing effectiveness of LLINs in controlling malaria transmission. In 2013, the Mozambi-
can NMCP chose to evaluate a LLIN distribution campaign in the northern province of Nam-
pula. Besides measuring coverage and falciparum malaria prevalence, additional components
were added to the evaluation to measure the prevalences and assess the impact of the campaign
on non-falciparum Plasmodium species. A further component was included to assess the addi-
tional impact of the LLIN campaign on LF; this was complex as both districts received MDAs
for LF during the evaluation period. These additional objectives were made possible by the
recent development of multiplex serology methods that allow detection of antibodies to
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multiple antigens simultaneously [11]. It was hypothesized that this laboratory technique
could detect changes in the levels of antibodies to various malaria and LF antigens following
the campaign, indicating changes in exposure to, and hence transmission of, malaria and LF
parasites as a result of the LLIN campaign.
Methods
Study design
Two consecutive cross-sectional household surveys were carried out one year apart, with the
first, baseline survey occurring two weeks following the mass LLIN distribution campaign in
2013. Achieved coverage with LLINs was assessed during the first survey, LLIN usage was
assessed during the follow-up survey one year later in 2014, and impact of the campaign was
assessed by comparison of biological markers of infection from the first and second surveys.
Study area and population
A LLIN distribution campaign encompassing six districts of the northern province of Nam-
pula was implemented in the second half of 2013. Of the six districts, two were purposefully
chosen to be included in the survey: the coastal district of Nacala-a-Velha, and Mecubu´ri Dis-
trict in the interior (S1 Fig). Both districts are predominantly rural. Nacala-a-Velha is in close
proximity to the port city of Nacala-Porto, and Mecubu´ri, although close to the provincial cap-
ital of Nampula, is particularly difficult to access. Both districts were classified as endemic for
LF as of 2013, and began undergoing annual MDAs of albendazole and ivermectin starting
2012 in Nacala-a-Velha and starting 2013 in Mecubu´ri. Administrative coverage for the MDAs
in Nacala-a-Velha and Mecubu´ri was 70% and 114%, respectively, in 2013 and 76% and 82%
in 2014.
For the survey, twenty enumeration areas (survey clusters) in each district were chosen ran-
domly with probability proportional to size from the full list of census enumeration areas for
each district. Four clusters in Mecubu´ri were inaccessible and were substituted with four ran-
domly chosen replacement clusters. Immediately prior to the start of the survey, trained enu-
merators visited each selected cluster and compiled a full list of households, recording the
name of head of household and the latitude/longitude coordinates of the household. For each
cluster, the list of households was randomly sorted, and in the first survey in 2013, survey
teams visited households according to the order of the list, continuing until 16 households
were visited per cluster. In the second survey in 2014, survey teams revisited households from
2013, matching households based on the name of head of household and coordinates, and no
replacement of households was allowed. In each household, all household members present
were invited to participate in the survey. The target sample size was 1,320 individuals and 367
households per district, designed to provide 80% power to detect a 10% change between the
two surveys in the proportion of the population testing positive for P. falciparum parasites,
assuming a baseline prevalence of 43% and a design effect of 3.
Data collection
Trained teams, each composed of a national-level supervisor and a district surveyor, visited
the selected households and, after obtaining consent, administered a household questionnaire.
Surveyors collected socioeconomic data, including occupation and education of the head of
household and household ownership of goods; generated a roster of household members; enu-
merated all sleeping spaces and recorded who slept in which sleeping space; visually inspected
each sleeping space and recorded the presence and location (hanging or stored) of the bed net
Multiplex serology and bed net impact on lymphatic filariasis and malaria
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006278 February 14, 2018 4 / 19
designated for that sleeping space, denoting whether or not the bed net bore the marking spe-
cific to the distribution campaign; and asked the interviewee about how often on average each
bed net was used during the wet and dry seasons. In both years, each household member,
regardless of age, present during the visit and providing written consent was administered a P.
falciparum HRP2-specific rapid diagnostic test (RDT) (SD Bioline, Yongin, Republic of
Korea), and had up to six 10 mcL spots of capillary blood collected on filter paper (TropBio,
Cellabs, Sydney, Australia). Individuals testing positive for malaria were treated by survey
teams in accordance with national treatment guidelines [12]. In 2014, the same questionnaires
and procedures were followed as in 2013, with an additional module where household mem-
bers were cross-linked to those in the first round based on name and age.
The surveys were carried out in September 2013 and October 2014 in Nacala-a-Velha and
December 2013 and November 2014 in Mecubu´ri, with data collection lasting three weeks for
each survey in each district.
Laboratory analysis
After collection in the field, the filter paper was dried overnight, placed into individual plastic
bags with desiccant sachets, and then refrigerated prior to shipment to central laboratories in
Maputo and later to CDC laboratories in Atlanta. Blood spots were eluted overnight at 4˚C at
a serum dilution of 1:40 (assuming 50% hematocrit) and further diluted in casein-containing
dilution buffer as previously described for a final dilution of 1:400 of serum [13, 14].
A multiplex bead platform [11] was used to measure immunoglobulin G (IgG) antibody
response to ten antigens: six malaria, three LF, and one control antigen (Strongyloides ster-
coralis) (S1 Table). The 19-kDa subunit of the merozoite surface protein 1 (MSP-119) from
each of the four main human malaria species was cloned and expressed as recombinant
Schistosoma japonicum glutathione-S-transferase (GST) fusion proteins [14–16]. A P. vivax
MSP-119 expression clone that included the carboxy-terminal hydrophobic tail sequence
was used [16]. A (NANP)5 peptide corresponding to the carboxy-terminus of the P. falcipa-
rum circumsporozoite protein (CSP) was cross-linked to GST and then coupled to a Sero-
Map bead as previously described [14]. The Pl1043 epitope from P. falciparum Liver Stage
Antigen 1 (LSA-1) [17] was synthesized and coupled to beads at a concentration of 60ug/
mL at pH 5.0. The Strongyloides stercoralis NIE antigen-GST fusion protein, GST fusion
partner with no inserted sequence, and the Brugia malayi Bm14- and Bm33-GST fusion
proteins were cloned and expressed as previously described [18–21]. W. bancrofti Wb123
antigen expressed as a GST fusion protein was a gift of T. Nutman (NIH, Bethesda, MD).
Although only W. bancrofti occurs in Africa, the serological test for the B. malayi antigens
cross-reacts with W. bancrofti.
With the exception of the P. vivax GST/MSP-119, all other antigens were coupled to Sero-
Map beads (Luminex Corp., Austin, TX) using the buffers and protein amounts previously
described [16]. The P. vivax antigen was coupled to a BioPlex COOH bead (BioRad, Hercules,
CA) using the protein amount and buffer previously specified [16]. Total IgG multiplex bead
assays were performed using the biotin-streptavidin system previously described [19, 20].
Assays included beads coated with the 10 proteins described above and an additional 31 anti-
gen-coated beads representing viral, bacterial, and parasitic diseases. Each assay plate included
a buffer-only blank and 6 control sera to ensure consistent assay performance throughout the
study. Assays were run in duplicate, and results were reported as the average of the two median
fluorescent intensity values minus the buffer-only blank value (MFI-bg). Samples (N = 8) that
had discordant result between the two runs (coefficient of variation >15%) for >4 positive
antigen responses were repeated.
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For malaria and LF antigens, cutoff values were determined using a panel of 81 presumed neg-
ative sera from adult US citizens who had no history of foreign travel. Values greater than the
mean plus 3 standard deviations of these negative control values were considered positive. For
the S. stercoralis NIE assay, a cutoff value determined by a receiver-operator characteristic curve
analysis using a different lot of coupled beads was translated to the current study bead set using a
2-fold serial dilution curve of a strong positive control sample as an inter-assay standard.
A subset of samples (20%) did not have full blood spots available; for these, partly filled
blood spots were analyzed. Comparison of average MFI-bg values from full and partial blood
spots revealed an average difference of<10%; thus, all samples were included in the final sta-
tistical analysis.
Statistical analysis
Demographic characteristics for the heads of household were tabulated, and a socioeconomic
status (SES) index was constructed and calculated for each household using a previously
described methodology [22]. Households were divided into equal quintiles based on the SES
index score. Key ownership, access, and usage indicators [23] were calculated separately for
each district. The proportion of the population testing positive for P. falciparum infection by
RDT was calculated for each district and year, stratifying by age. Estimation of coverage indi-
cators and malaria positivity was adjusted taking into account the complex sample design
using the R survey package [24]. Data were weighted by the inverse of the probability of selec-
tion, calculated as the product of the probability of selection for the cluster, the household,
and, where applicable, the individual.
For each of the antigens the mean seropositivity, defined as the percent of individuals with
MFI-bg above the predetermined threshold, was calculated for the total population and also
stratifying by ten age categories. A reversible catalytic model was fit to the seropositivity by age
data for each antigen, and the estimates for the serological conversion rate (SCR) and serologi-
cal reversion rate (SRR) per year were directly calculated from the likelihood model [25]. The
SRR was assumed to be constant for both districts and both years, but the SCR was separately
calculated for each district and each year of the survey. For each antigen, the average of the
population log MFI-bg value was calculated for each district and year, and the 95% confidence
intervals were calculated assuming a normal distribution of the log MFI-bg values. The Stron-
gyloides NIE antigen was included as a control antigen to aid in discriminating between the
effects of the LLIN and MDA campaigns, as Strongyloides transmission was presumed to be
unaffected by the LLIN campaigns but sensitive to the MDA campaigns.
Poisson regression, which allows direct estimation of the relative risk, [26] was used to model
the association between individual- and cluster-level LLIN use and ten binary biological out-
comes in individuals sampled in the second survey: RDT positivity and seropositivity for the six
malaria and three LF antigens. Each model was fit adjusting for age, sex, and household SES. Use
of LLIN was quantified on a 0 to 1 scale by a principal components analysis of data on LLIN loca-
tion and reported use during the wet and dry season, as previously described [23]. The individual
and community effects were jointly estimated by normalizing the individual-level variable by
subtracting the average cluster-level value from the individual-level variable [27].
All statistical analyses were performed in R version 3.3.2 (R Foundation for Statistical Com-
puting, Vienna, Austria).
Ethical considerations
The study was approved by the National Bioethics Committee in Mozambique. Adult partici-
pants provided written consent prior to enrollment in the study, and also provided written
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consent on behalf of child participants. CDC investigators provided technical assistance and
were not considered to be engaged in the research.
Results
A total of 282 households in Nacala-a-Velha and 300 households in Mecubu´ri were visited in
the first survey in 2013 (Table 1). The total number of people living in these households was
1,172 in Nacala-a-Velha and 1,443 in Mecubu´ri, and of these, 539 (46%) household members
in Nacala-a-Velha and 598 (41%) in Mecubu´ri were present and consented to have blood
drawn during the survey. In the follow up survey in 2014, 81% (228/282) of the households in
Nacala-a-Velha and 72% (217/300) in Mecubu´ri were revisited; a total of 578 household mem-
bers in Nacala-a-Velha and 704 in Mecubu´ri were sampled in the second survey.
The coverage attained by the LLIN distribution campaign was low (Table 2). The campaign
reached 80% (95% CI: 72–86) of households in Nacala-a-Velha and 54% (44–65) in Mecubu´ri,
but only 58% (48–67) of households in Nacala-a-Velha and 36% (29–43) in Mecubu´ri received
at least one LLIN per sleeping space. The proportion of the population sleeping in spaces with
an available LLIN was 68% (58–77) in Nacala-a-Velha and 46% (37–56) in Mecubu´ri. Usage of
any LLIN in the year following the distribution campaign was also low, with only 40% (27–55)
of the population in Nacala-a-Velha and 23% (17–30) in Mecubu´ri reporting having used
LLINs more than 4 times per week during the wet season, falling to 21% (14–30) and 17% (13–
22), respectively, in the dry season.
There was no statistically significant change in P. falciparum RDT positivity from 2013 in
2014 in either district with overlapping 95% confidence intervals, although the point estimates
for RDT positivity were higher in 2014 versus 2013 (Table 3). One year after the campaign,
RDT positivity in the key<5 year age group was 61% (95% CI: 44–76) in Nacala-a-Velha and
87% (76–94) in Mecubu´ri. Overall, RDT positivity was significantly higher in Mecubu´ri than
in Nacala-a-Velha.
The serological data confirm high P. falciparum transmission in both districts. Virtually all
sampled individuals were positive for P. falciparum MSP-119 antibodies, with very high anti-
body responses (S2 Fig) even in infants, indicating that individuals’ first P. falciparum infection
likely occurs early in infancy. Seropositivity for P. falciparum CSP also eventually reached satu-
ration, with close to 100% of the older age categories testing positive, but the slope of the
Table 1. Demographic data on study population of household surveys in Nacala-a-Velha and Mecubu´ri Districts,
Mozambique, 2013–2014.
Nacala-a-Velha Mecubu´ri
2013 2014 2013 2014
Households visited 282 228 300 217
Total household members 1172 908 1443 971
Total household members sampled 539 578 598 704
<5 years 124 (23%) 123 (21%) 131 (22%) 146 (21%)
5–14 years 142 (26%) 163 (28%) 142 (24%) 219 (31%)
>14 years 273 (51%) 292 (51%) 325 (54%) 339 (48%)
Female 299 (55%) 310 (54%) 326 (55%) 384 (55%)
Household members sampled both years 275 302
<5 years 45 (16%) 53 (18%)
5–14 years 87 (32%) 89 (29%)
>14 years 143 (52%) 160 (53%)
Female 159 (58%) 175 (58%)
https://doi.org/10.1371/journal.pntd.0006278.t001
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seropositivity by age curve was more gradual (Fig 1). In contrast to the other two P. falciparum
antigens, seropositivity to P. falciparum LSA-1 in general did not surpass 40% for any age
group.
For both P. falciparum CSP and P. falciparum LSA-1 antigens, the SCR was higher in Mecu-
bu´ri than Nacala-a-Velha, consistent with the difference in RDT positivity by district. Gener-
ally, there was no statistically significant difference in SCR between the two years for these
antigens (t-test p-values ranging from 0.07 to 0.35) (Table 4). The only difference approaching
statistical significance was a slightly lower SCR for P. falciparum CSP in 2014 versus 2013 in
Nacala-a-Velha, which fell by 15% (t-test p-value 0.07).
Table 2. Coverage with LLINs immediately following a mass LLIN distribution campaign in 2013 in Nacala-a-
Velha and Mecubu´ri Districts, Mozambique.
Nacala-a-
Velha
Mecubu´ri
% (95% CI) % (95% CI)
Ownership1
Households receiving at least one campaign LLIN 80 (72–86) 54 (44–65)
Access1
Households receiving at least one LLIN per sleeping space 58 (48–67) 36 (29–43)
Sleeping spaces covered by campaign LLIN 66 (58–74) 43 (35–52)
People with access to campaign LLIN 68 (58–77) 46 (37–56)
Usage2
Sleeping spaces with a hung campaign LLIN 30 (19–43) 17 (11–23)
Sleeping spaces with a campaign LLIN reported to be used4 times a week during
dry season3
21 (14–30) 17 (13–22)
Sleeping spaces with a campaign LLIN reported to be used4 times a week during
wet season3
40 (27–55) 23 (17–30)
1Assessed immediately following campaign
2Assessed one year after campaign
3In preceding year, self-reported
LLIN: long-lasting insecticidal net
https://doi.org/10.1371/journal.pntd.0006278.t002
Table 3. Prevalence of P. falciparum infection as assessed by RDT immediately following and one year after an
LLIN distribution campaign in Nacala-a-Velha and Mecubu´ri Districts, Mozambique.
% RDT+ (95% Confidence Interval)
2013 2014
Nacala-a-Velha
All ages 44 (33–56) 48 (35–61)
<5 years 52 (36–67) 61 (44–76)
5–14 years 63 (34–87) 67 (38–89)
>14 years 30 (22–40) 30 (22–39)
Mecubu´ri
All ages 65 (56–74) 70 (64–76)
<5 years 67 (52–80) 87 (76–94)
5–14 years 89 (77–96) 93 (87–97)
>14 years 54 (43–65) 49 (41–56)
LLIN: long-lasting insecticidal net
RDT: rapid diagnostic test
https://doi.org/10.1371/journal.pntd.0006278.t003
Multiplex serology and bed net impact on lymphatic filariasis and malaria
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Fig 1. Seropositivity by age for antibodies to three P. falciparum antigens in community members sampled during household
surveys in Nacala-a-Velha and Mecubu´ri Districts, Northern Mozambique, 2013–2014. Points represent estimates and 95%
confidence intervals for seropositivity for each age category, curves represent the fit of a catalytic conversion model, and shaded areas
represent the 95% confidence intervals of model fit: blue for 2013, red for 2014, and purple for the overlap.
https://doi.org/10.1371/journal.pntd.0006278.g001
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Robust antibody responses to the three other Plasmodium species were detected in both
young and old individuals in both districts (Fig 2, S3 Fig), an indication of ongoing transmis-
sion of all three other species. After P. falciparum, the species registering the highest seroposi-
tivity was P. malariae, with 46% (95%CI: 42–50) of the population in 2013 in Nacala-a-Velha
and 56% (52–60) in Mecubu´ri seropositive for antibodies against P. malariae MSP-119, with a
corresponding SCR of 0.068 (0.054–0.081) in Nacala-a-Velha and 0.095 (0.077–0.11) in Mecu-
bu´ri. Similar levels of exposure were observed for P. ovale, with the proportion of the popula-
tion with antibodies to P. ovale MSP-119 in 2013 ranging from 41% (37–45) in Nacala-a-Velha
to 43% (39–47) in Mecubu´ri, and an SCR estimated to be 0.12 (0.087–0.15) in Nacala-a-Velha
and 0.13 (0.093–0.16) in Mecubu´ri. Much lower levels of antibody positivity to P. vivax were
observed, with only 2.7% (1.5–4.5) of the population in Nacala-a-Velha and 3.9% (2.5–5.9) in
Mecubu´ri with detectable antibodies to P. vivax MSP-119. There was a statistically significant
difference in SCR for P. malariae between the two surveys in Nacala-a-Velha, with the estimate
for SCR for 2014 24% lower than in 2013 (t-test p-value 0.03). There was a similar reduction in
the SCR for P. ovale in Nacala-a-Velha, with a 22% reduction, but this was not statistically sig-
nificant (t-test p-value 0.096). The SCRs for P. malariae and P. ovale in Mecubu´ri did not show
a similar reduction, falling by only 1% and 3%, respectively, with neither antigen showing a
statistically significant difference in SCR between the two surveys (t-test p-values ranging from
0.43 to 0.46).
The absolute levels of antibody response and seropositivity by age curves for the three LF
antigens were consistent with the geographic distraction of LF (Fig 3, S4 Fig). The highest rates
of seropositivity at baseline were to the Bm33 antigen, with 67% (95%CI: 56–65) of the popula-
tion in 2013 in Nacala-a-Velha and 76% (72–79) in Mecubu´ri seropositive, compared to 37%
(33–41) in Nacala-a-Velha and 45% (41–49) in Mecubu´ri seropositive for antibodies against
Bm14, and 50% (46–54) in Nacala-a-Velha and 41% (37–45) in Mecubu´ri seropositive for anti-
bodies against Wb123 (Table 4). There were significant reductions in SCR for the LF antigens
between the two surveys in Nacala-a-Velha, with the SCR for Wb123 declining by 27% (chi-
square test p-value 0.011), the SCR for Bm14 declining by 17% (chi-square test p-value 0.084),
and the SCR for Bm33 declining by 22% (chi-square test p-value 0.026). In Mecubu´ri, the SCR
fell by 19% for Wb123 (t-test p-value 0.052), 31% for Bm14 (t-test p-value <0.001), and 59%
for Bm33 (t-test p-value<0.001).
A substantial proportion of the population in Nacala-a-Velha (58%, 95%CI: 53–62) and
Mecubu´ri (65%, 95%CI: 61–69) had antibodies against the control Strongyloides NIE antigen in
2013. In Nacala-a-Velha, there was no statistically significant difference in SCR (t-test p-value
0.26) or seropositivity (chi-square p-value 0.53) to the NIE antigen between the two surveys,
whereas Mecubu´ri witnessed statistically significant declines of 35% for the NIE SCR (t-test
p-value<0.01) and 17% for NIE seropositivity (chi-square p-value<0.01) from 2013 to 2014.
The achieved sample size was lower than the target sample size, due to a lower than
expected number of people tested per household (2.4 vs 3.6). Although there was no detected
change in overall P. falciparum RDT positivity from 2013 to 2014, both individual- and clus-
ter-level LLIN use was associated with lower risk for P. falciparum RDT positivity in the second
year after adjusting for age, sex, and SES (Table 5). The relative risk for testing RDT positive in
LLIN users compared to non-users was 0.81 (95%CI: 0.64–1.0). Moreover, the relative risk of
RDT positivity for the individuals living in clusters where everyone would be sleeping under
an LLIN was estimated to be 0.43 (0.24–0.77) compared to individuals living in clusters with
no LLIN use, demonstrating the indirect effects of LLINs, independent of individual use of
LLINs. Cluster-level LLIN use was also associated with lower risk for seropositivity to P. falcip-
arum LSA-1 and P. malariae MSP-119 antigens. In contrast, no significant protective effect
of individual- or community-level LLIN use on LF, P. vivax MSP-119, and P. ovale MSP-119
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antibody positivity was observed. Generally, RDT positivity and seropositivity to all antigens
decreased with increasing SES. P. falciparum RDT positivity was negatively associated with
age, in contrast to antibody seropositivity, which increased with age for all antigens.
Discussion
The high rates of P. falciparum RDT positivity observed in these surveys, coupled with the
high rates and age distribution of antibody levels to P. falciparum antigens, confirm holoen-
demic transmission of P. falciparum in the survey area. The levels of RDT positivity are par-
ticularly striking given that the surveys were conducted at the end of the dry season, when
transmission would be expected to be lowest. Areas of large malaria burden would benefit
most from a mass LLIN campaign. However, the coverage indicators provide evidence that the
LLIN campaign evaluated here was far from reaching its intended target of universal coverage.
Reported usage, ranging from 17% to 40%, was far removed from the 65% threshold postulated
to be necessary in providing a demonstrable community reduction in malaria incidence [28].
Nevertheless, those individuals using LLINs and living in clusters with high overall usage of
LLINs did have significantly lower risk for testing positive for P. falciparum infection by RDT,
mirroring results from previous studies of LLIN effectiveness in Mozambique [22] and con-
firming the continued effectiveness of LLINs as a malaria prevention strategy in Mozambique.
Table 4. Change in serological indicators of malaria and lymphatic filariasis exposure immediately following and one year after an LLIN distribution campaign in
Nacala-a-Velha and Mecubu´ri Districts, Mozambique.
Serological conversion rate log Median Fluorescent Intensity
(paired analysis)
Seroposivity
2013 2014 % change p-value 2013 2014 % change p-value 2013 2014 % change p-value
Nacala-a-Velha
P. falciparum MSP-119 antigen 2.263 2.271 0% 0.50 3.688 3.782 3% 0.208 80% 80% 0% 0.99
P. falciparum CSP antigen 0.087 0.074 -15% 0.07 3.493 3.494 0% 0.986 61% 58% -5% 0.33
P. falciparum LSA-1 antigen 0.17 0.144 -15% 0.35 2.198 2.227 1% 0.617 31% 28% -10% 0.27
P. vivax MSP-119 antigen 0.002 0.001 -38% 0.20 2.279 2.238 -2% 0.24 3% 2% -37% 0.37
P. ovale MSP-119 antigen 0.118 0.092 -22% 0.10 2.076 2.1 1% 0.632 41% 35% -14% 0.06
P. malariae MSP-119 antigen 0.068 0.051 -24% 0.03 2.689 2.641 -2% 0.556 46% 40% -14% 0.04
W. bancrofti Wb123 antigen 0.074 0.054 -27% 0.01 2.502 2.402 -4% 0.16 50% 43% -15% 0.02
B. malayi Bm14 antigen 0.031 0.026 -17% 0.08 2.282 2.191 -4% 0.323 37% 32% -12% 0.16
B. malayi Bm33 antigen 0.169 0.131 -22% 0.03 3.087 3.002 -3% 0.066 67% 61% -10% 0.04
Strongyloides NIE antigen (control) 0.125 0.114 -8% 0.26 3.265 3.198 -2% 0.278 58% 56% -4% 0.53
Mecubu´ri
P. falciparum MSP-119 antigen 2.382 2.151 -10% 0.42 3.764 3.741 -1% 0.729 81% 80% -2% 0.61
P. falciparum CSP antigen 0.125 0.133 7% 0.27 3.677 3.709 1% 0.631 71% 71% 0% 0.99
P. falciparum LSA-1 antigen 0.184 0.224 22% 0.32 2.342 2.324 -1% 0.773 33% 38% 15% 0.09
P. vivax MSP-119 antigen 0.003 0.001 -53% 0.07 2.331 2.211 -5% 9E-04 4% 2% -54% 0.04
P. ovale MSP-119 antigen 0.125 0.121 -3% 0.43 2.153 2.114 -2% 0.412 43% 42% -2% 0.78
P. malariae MSP-119 antigen 0.095 0.094 -1% 0.46 2.919 2.912 0% 0.918 56% 54% -3% 0.59
W. bancrofti Wb123 antigen 0.048 0.039 -19% 0.05 2.321 2.203 -5% 0.043 41% 35% -15% 0.03
B. malayi Bm14 antigen 0.044 0.03 -31% 8.E-04 2.438 2.289 -6% 0.12 45% 34% -23% 2.E-04
B. malayi Bm33 antigen 0.246 0.101 -59% 2.E-09 3.146 2.885 -8% 9E-09 76% 55% -27% 1.E-13
Strongyloides NIE antigen (control) 0.163 0.105 -35% 9.E-04 3.43 3.242 -5% 0.005 65% 54% -17% 8.E-05
P-values for differences in serological conversion rate were derived with a normal distribution test, log Median Fluorescent Intensity with a two-sample t-test, and
seropositivity with Pearson’s chi-squared test
https://doi.org/10.1371/journal.pntd.0006278.t004
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Fig 2. Seropositivity by age for antibodies to P. ovale, P. malaria, and P. vivaxMSP-119 antigens in community members sampled
during household surveys in Nacala-a-Velha and Mecubu´ri Districts, Northern Mozambique, 2013–2014. Points represent
estimates and 95% confidence intervals for seropositivity for each age category, curves represent the fit of a catalytic conversion model,
and shaded areas represent the 95% confidence intervals of model fit: blue for 2013, red for 2014, and purple for the overlap.
https://doi.org/10.1371/journal.pntd.0006278.g002
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Fig 3. Seropositivity by age for antibodies to three lymphatic filariasis antigens and the Strongyloides NIE (control) antigen in
community members sampled during household surveys in Nacala-a-Velha and Mecubu´ri Districts, Northern Mozambique,
2013–2014. Points represent estimates and 95% confidence intervals for seropositivity for each age category, curves represent the fit of a
catalytic conversion model, and shaded areas represent the 95% confidence intervals of model fit: blue for 2013, red for 2014, and purple
for the overlap.
https://doi.org/10.1371/journal.pntd.0006278.g003
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This study highlights the added benefit of simultaneously measuring seropositivity to mul-
tiple antigens to estimate P. falciparum transmission intensity. The results show that not all
antigens are consistently informative in this setting. For example, the P. falciparum MSP-119
antigen, which to date has been one of the standard antigens used to assess population-level
P. falciparum exposure [25, 29] provides little information on changes in P. falciparum inten-
sity in a setting of such high transmission as northern Mozambique. The transmission inten-
sity is such that virtually all sampled individuals regardless of age had antibodies to MSP-119,
evidence that the first P. falciparum infection likely occurs in early infancy. However, the two
other P. falciparum antigens included in the assay, CSP and LSA-1, generated seroprevalence
curves with increasing likelihood of transitioning to seropositive with increasing age. Both
antigens are thought to be less immunogenic than MSP-119, and the data presented here sug-
gest that repeated P. falciparum infections throughout life are needed to generate a consistently
Table 5. Relative risk for malaria and lymphatic filariasis outcomes one year after an LLIN distribution campaign in Nacala-a-Velha and Mecubu´ri Districts,
Mozambique, as a function of demographic, socioeconomic, and bed net usage factors.
Antibody seropositivity in 2014
Malaria RDT
+ in 2014
P. falciparum
MSP-119
P. falciparum
CSP
P. falciparum
LSA-1
P. vivax
MSP-119
P. ovale
MSP-119
P. malariae
MSP-119
W. bancrofti
Wb123
B. malayi
Bm14
B. malayi
Bm33
Age
<5 yrs Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
5–10 yrs 1.1 (0.92–1.3) 0.99 (0.8–1.2) 2.1 (1.5–3) 1.1 (0.81–1.6) 2.8 (0.29–
27)
1.6 (1.2–
2.3)
2.2 (1.6–3.2) 1.0 (0.68–1.6) 2.7 (1.2–
6.1)
1.5 (1.1–
2.1)
10–15 yrs 1.1 (0.85–1.3) 1.1 (0.84–1.4) 3.4 (2.4–4.8) 1 (0.68–1.6) 4.3 (0.39–
48)
1.6 (1.1–
2.4)
2.7 (1.8–4) 1.9 (1.2–2.9) 8.9 (4.1–
19)
2.1 (1.5–
2.9)
15–20 yrs 0.82 (0.61–
1.1)
1.2 (0.91–1.6) 4.2 (2.9–6.1) 0.9 (0.52–1.6) 1e-06
(0-Inf)
2.0 (1.3–
3.1)
2.8 (1.8–4.4) 3.6 (2.3–5.6) 18 (8.4–
39)
3.0 (2.1–
4.3)
20–30 yrs 0.56 (0.43–
0.73)
1.2 (0.99–1.6) 4.2 (3.1–5.8) 1.6 (1.1–2.3) 7.9 (0.91–
67)
1.7 (1.2–
2.5)
3.3 (2.3–4.7) 3.5 (2.4–5.2) 15 (7.5–
32)
2.6 (1.9–
3.5)
30–40 yrs 0.46 (0.34–
0.63)
1.3 (1–1.7) 4.4 (3.2–6.2) 1.5 (1.1–2.2) 7.2 (0.8–
65)
1.9 (1.3–
2.8)
3.6 (2.5–5.2) 3.8 (2.6–5.6) 17 (8.4–
36)
2.7 (2–3.6)
>40 yrs 0.31 (0.23–
0.42)
1.3 (1.1–1.7) 4.5 (3.3–6.2) 1.8 (1.3–2.5) 6.8 (0.79–
59)
2.5 (1.8–
3.4)
4.2 (3–5.9) 3.9 (2.7–5.6) 20 (9.7–
40)
2.8 (2.1–
3.7)
Sex
Female Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Male 1.0 (0.9–1.2) 0.87 (0.76–
0.99)
0.98 (0.85–
1.1)
0.92 (0.75–1.1) 1.4 (0.59–
3.5)
0.8 (0.66–
0.97)
1.0 (0.84–1.2) 1.2 (1–1.5) 1.3 (1–1.6) 0.95
(0.81–1.1)
SES quintile
1st (Poorest) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
2nd 0.94 (0.75–
1.2)
0.96 (0.77–1.2) 1.1 (0.84–1.4) 1.1 (0.82–1.6) 5.7 (0.63–
51)
1.2 (0.89–
1.7)
1.1 (0.86–1.5) 0.94 (0.68–
1.3)
0.80
(0.57–1.1)
1.0 (0.77–
1.3)
3rd 0.90 (0.72–
1.1)
0.99 (0.8–1.2) 0.99 (0.78–
1.2)
0.94 (0.68–1.3) 3.5 (0.36–
34)
1.3 (0.94–
1.7)
1 (0.78–1.3) 0.93 (0.7–1.2) 0.78
(0.57–1.1)
0.98
(0.76–1.2)
4th 0.87 (0.7–1.1) 0.94 (0.76–1.2) 0.96 (0.76–
1.2)
0.89 (0.64–1.2) 7.9 (0.95–
65)
1.1 (0.79–
1.5)
0.92 (0.71–
1.2)
0.91 (0.68–
1.2)
0.77
(0.57–1.1)
0.96
(0.75–1.2)
5th (Richest) 0.80 (0.64–
0.99)
0.95 (0.78–1.2) 0.96 (0.77–
1.2)
1.0 (0.76–1.4) 4.6 (0.52–
41)
0.99
(0.73–1.3)
0.87 (0.66–
1.1)
0.8 (0.59–1.1) 0.71
(0.52–
0.97)
0.98
(0.77–1.3)
LLIN Use
(individual)
0.81 (0.64–
1.0)
0.99 (0.82–1.2) 0.98 (0.79–
1.2)
1.1 (0.82–1.5) 0.85 (0.23–
3.1)
1.0 (0.8–
1.4)
0.98 (0.76–
1.3)
1.1 (0.83–1.4) 0.97
(0.73–1.3)
1.0 (0.81–
1.3)
LLIN Use
(community)
0.43 (0.24–
0.77)
1.0 (0.6–1.7) 0.71 (0.39–
1.3)
0.34 (0.15–
0.79)
0.22
(0.0062–8)
0.67
(0.31–1.5)
0.4 (0.2–0.81) 2.0 (0.95–4.4) 0.98
(0.43–2.3)
3.7 (2–6.9)
RDT: rapid diagnostic test; SES: socioeconomic status; LLIN: long-lasting insecticidal net
https://doi.org/10.1371/journal.pntd.0006278.t005
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high antibody level to each antigen. Due to the slower acquisition of antibodies to these two
antigens, the seroprevalence by age data were informative, allowing differentiation between
the higher transmission in Mecubu´ri versus Nacala-a-Velha, an observation also seen in the
RDT positivity data. Additionally, P. falciparum LSA-1 seropositivity was lower in LLIN users,
further evidence of the protective effect of LLINs against P. falciparum infection.
In addition to the two districts being a setting of very high P. falciparum transmission, the
populations in both districts showed substantial serological responses to P. ovale and P. malar-
iae antigens. A small but non-zero proportion of the population showed evidence of exposure
to P. vivax, consistent with the results of a 2015 household survey which showed a national
0.2% P. vivax prevalence in children under 5 years of age [2]. MSP-119 antigen competition
studies have not indicated antibody cross-reactivity in most individuals [14], and species-spe-
cific MSP-119 antibody responses were common even among patients who had high responses
to multiple malaria MSP-119 antigens. Although the MSP-119 antigens from P. vivax and P. fal-
ciparum share 51% identity at the amino acid level, some of the conserved residues are cyste-
ines and other hydrophobic amino acids that are unlikely to be exposed to the immune
response [30]. Bousema et al. used the two MSP-119 antigens in ELISA studies of sera from a
population living in a region endemic for both parasites and did not observe any correlation
between the P. vivax and P. falciparum antibody responses [31]. In a separate study, 79% of
women who were positive for antibodies to malaria reacted with the MSP-119 antigen from
only one species [16]. Thus, it is unlikely that the observed antibody responses to P. malariae
and P. ovale antigens can be solely attributed to assay cross-reactivity.
Although subject to many limitations, the SCR at its most basic definition is a measure of
incidence, the annual rate at which individuals acquire antibodies to a certain antigen [32].
Taken at face value, the SCRs estimated for P. ovale MSP-119 and P. malariae MSP-119 in these
two districts in 2013 suggest an annual incidence of P. ovale infection of 125/1000 in Nacala-a-
Velha and 133/1000 in Mecubu´ri, and an annual incidence of P. malariae infection of 70/1000
in Nacala-a-Velha and 100/1000 in Mecubu´ri. This magnitude of incidence would elevate P.
ovale and P. malariae as major contributors to malaria burden in northern Mozambique.
In contrast to P. falciparum, there was a statistically significant population-level decrease in
P. malariae seropositivity and a borderline significant decrease in P. ovale seropositivity from
2013 to 2014 in one of the districts. Since LLIN use was associated with lower post-campaign
risk of testing positive for P. malariae antibodies, there is evidence that the LLIN campaign, at
least in Nacala-a-Velha where coverage was higher, might have had an impact on decreased P.
malariae transmission. The fact that there were detectable changes in seroprevalence and dis-
tribution of P. ovale and P. malariae markers and no change in P. falciparum might be due to
the differences in magnitude of transmission intensity. One hypothesis is that with such high
levels of P. falciparum transmission, there would need to be a much larger decrease in vectorial
capacity to result in a detectable change in incidence, whereas non-falciparum transmission
might be low enough to be sensitive to smaller changes in vectorial capacity.
In both districts there was evidence of significant declines in LF transmission between 2013
and 2014, as seen by decreases in both the SCR and overall proportion of the population sero-
positive for the LF antigens. The results are robust as they hold across all three different LF
antigens included in the assay. However, attributing this change to the LLIN distribution cam-
paign is hampered by the concurrent MDAs of antiparasitic drugs in both districts. Ivermectin
is effective against LF microfilariae, in addition to a postulated killing effect on mosquitos feed-
ing on individuals treated with ivermectin, and albendazole kills adult worms. Together, the
two-drug combination could be expected to influence antibody levels through its effect on
transmission and worm load. In Mecubu´ri, the substantial declines in SCR and proportion of
the population seropositive for the NIE Strongyloides antigen, which should be influenced by
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the MDAs but not by the LLIN campaign, suggest that there was high enough coverage from
the antiparasitic MDAs to reduce LF transmission. In Nacala-a-Velha, however, there was no
significant difference in NIE Strongyloides SCR and seropositivity between the two surveys,
and thus the population-level declines in SCR and seropositivity to LF antigens could be due
to the LLIN distribution campaign. Overall, there was no association between individual or
community LLIN use and seropositivity to LF antigens. Given the confounding due to the con-
current use of MDAs in the survey districts, this result cannot be interpreted as evidence of no
effect, as the effect might have been masked by the antifilarial MDAs.
Several aspects of the study’s design prevent direct inference of a causal relationship between
the LLIN distribution campaign and the observed changes in malaria positivity and serological
outcomes for malaria and LF. The lack of a control group and the MDA campaigns in the inter-
vening year hamper direct estimation of the impact of the LLIN campaign. In addition, the low
coverage and usage resulting from the LLIN campaign and the lower-than-expected sample size
limited the ability of the study to assess the impact of LLINs on malaria and LF transmission.
Additionally, as IgG against some antigens is known to persist for years following infection [33],
more elapsed time may be needed to detect a substantial change in serological metrics following a
successful intervention. The extraordinarily high rates of P. falciparum transmission on the back-
drop of low LLIN coverage argue for follow-up campaigns in these two districts, both of which
will take part in the nationwide universal coverage campaign in Mozambique launched in 2016.
Similar evaluations are recommended to evaluate coverage and usage of future campaigns. Finally,
the results presented here provide evidence for the enhanced utility of the multi-antigenic and
multi-disease assay for quantifying baseline exposure to the non-falciparum malarias and LF, and
evaluating the impact of vector control intervention campaigns on these diseases.
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